9 November 2016
joint SCI Colloid & Surface Chemistry Group and RSC Colloid & Interface Science Group, the Formulation Science and Technology Group (FSTG), the Academy of Pharmaceutical Sciences (APS), with valuable assistance from the Health Tech and Medicines Knowledge Transfer Network (Health KTN)
This event is no longer available for registration.
The MIBio conference series engages world leading experts from industry and academia in a discussion on how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly and safer therapeutic products.
With the increasing number of biopharmaceutical products in the pipeline, formulation as well as drug-device integration are becoming important issues. Only products that combine an excellent stability profile and a convenient delivery device will succeed in the increasingly competitive market place. The aim of the MIBio series is to facilitate a discussion about the latest advances in molecular interactions, formulation strategies and device development and to assist in effective translation of these advances into state-of the-art biopharmaceutical development.
MIBio 2016 will focus on discussing present and future drug-device development and the need for creative formulation to support successful product strategies. This will include formulation strategies for new product formats, use of novel excipients and the use of computational approaches in the formulation and drug delivery design, as well as regulatory and strategic implications of these new approaches. Seven key experts in the field will present during the day on these topics, and, as is traditional in the MIBio series, there will be opportunities for audience participation in the discussion of these important matters.
Magdalene CollegeMagdalene College
For more information on available packages, please contact conference secretariat via firstname.lastname@example.org